Why do we keep coming back to this topic? MNTA would make a great addition to a number of great companies however Teva is not one of them (FTC issues)...
What am I missing? Is there something beyond TEVA's taking ownership of m-enox and generic Copaxone that makes such a purchase undesirable/insurmountable?
I would think that TEVA would *love* to have MNTA's technology for their general usage, but all I currently understand that would be in their way is matters centering around m-enox and Copaxone, which, as you said, the FTC would protest vociferously. Are there others I'm not aware of or have missed?